switching from sema to tirzepatide Semaglutide Safely Switching from Tirzepatide to Semaglutide:

How do I store reconstituted 5-Amino-1MQ solution to maintain its potency

GLP-1 boosts insulin production, limits glucagon release, slows down digestion, and promotes feelings of fullness

Risultati e studi clinici Studi recenti (SURMOUNT-5, NEJM 2025) hanno evidenziato che la tirzepatide, alla dose di 15 mg/settimana, in grado di indurre una riduzione media del peso corporeo del 26,6% in 88 settimane, significativamente superiore a quella ottenuta con semaglutide 2.4 mg (18,2%)

Given that the observed changes are relatively slight compared to those caused by pregnancy itself, their clinical impact is likely limited